{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:07:21Z","timestamp":1774397241858,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T00:00:00Z","timestamp":1380672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00406-013-0451-y","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T09:56:57Z","timestamp":1380621417000},"page":"155-168","source":"Crossref","is-referenced-by-count":22,"title":["Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia"],"prefix":"10.1007","volume":"263","author":[{"given":"Berend","family":"Malchow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schneider-Axmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Jatzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wobrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,2]]},"reference":[{"key":"451_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1073858410395147","volume":"18","author":"F Adriano","year":"2012","unstructured":"Adriano F, Caltagirone C, Spalletta G (2012) Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 18:180\u2013200","journal-title":"Neuroscientist"},{"key":"451_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.07.007","volume":"123","author":"F Adriano","year":"2010","unstructured":"Adriano F, Spoletini I, Caltagirone C, Spalletta G (2010) Updated meta-analyses reveal thalamus volume reduction in patients with first-episode and chronic schizophrenia. Schizophr Res 123:1\u201314","journal-title":"Schizophr Res"},{"key":"451_CR3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2008.01.005","volume":"101","author":"D Arnone","year":"2008","unstructured":"Arnone D, McIntosh AM, Tan GM, Ebmeier KP (2008) Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophr Res 101:124\u2013132","journal-title":"Schizophr Res"},{"key":"451_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2007.11.029","volume":"99","author":"SS Bangalore","year":"2008","unstructured":"Bangalore SS, Prasad KM, Montrose DM, Goradia DD, Diwadkar VA, Keshavan MS (2008) Cannabis use and brain structural alterations in first episode schizophrenia\u2014a region of interest, voxel based morphometric study. Schizophr Res 99:1\u20136","journal-title":"Schizophr Res"},{"key":"451_CR5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0920-9964(93)90033-F","volume":"11","author":"AS Bassett","year":"1993","unstructured":"Bassett AS, Collins EJ, Nuttall SE, Honer WG (1993) Positive and negative symptoms in families with schizophrenia. Schizophr Res 11:9\u201319","journal-title":"Schizophr Res"},{"key":"451_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0893-133X(99)00096-2","volume":"22","author":"A Bertolino","year":"2000","unstructured":"Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR (2000) The relationship between dorsolateral prefrontal neuronal n-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 22:125\u2013132","journal-title":"Neuropsychopharmacology"},{"key":"451_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/JCP.0b013e31820e3f58","volume":"31","author":"G Boonstra","year":"2011","unstructured":"Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS (2011) Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. J Clin Psychopharmacol 31:146\u2013153","journal-title":"J Clin Psychopharmacol"},{"key":"451_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1017\/S1121189X00005558","volume":"11","author":"P Brambilla","year":"2002","unstructured":"Brambilla P, Barale F, Caverzasi E, Soares JC (2002) Anatomical MRI findings in mood and anxiety disorders. Epidemiol Psichiatr Soc 11:88\u201399","journal-title":"Epidemiol Psichiatr Soc"},{"key":"451_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2001-18037","volume":"34","author":"DF Braus","year":"2001","unstructured":"Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA (2001) Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 34:251\u2013253","journal-title":"Pharmacopsychiatry"},{"key":"451_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(02)00003-2","volume":"12","author":"DF Braus","year":"2002","unstructured":"Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA (2002) Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol 12:145\u2013152","journal-title":"Eur Neuropsychopharmacol"},{"key":"451_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2010.10.004","volume":"69","author":"S Brugger","year":"2011","unstructured":"Brugger S, Davis JM, Leucht S, Stone JM (2011) Proton magnetic resonance spectroscopy and illness stage in schizophrenia\u2014a systematic review and meta-analysis. Biol Psychiatry 69:495\u2013503","journal-title":"Biol Psychiatry"},{"key":"451_CR12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/schbul\/sbn135","volume":"35","author":"PF Buckley","year":"2009","unstructured":"Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009) Psychiatric comorbidities and schizophrenia. Schizophr Bull 35:383\u2013402","journal-title":"Schizophr Bull"},{"key":"451_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(01)00249-3","volume":"54","author":"B Buhler","year":"2002","unstructured":"Buhler B, Hambrecht M, Loffler W, an der Heiden W, Hafner H (2002) Precipitation and determination of the onset and course of schizophrenia by substance abuse\u2014a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 54:243\u2013251","journal-title":"Schizophr Res"},{"key":"451_CR14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0920-9964(03)00003-3","volume":"67","author":"W Cahn","year":"2004","unstructured":"Cahn W, Hulshoff Pol HE, Caspers E, van Haren NE, Schnack HG, Kahn RS (2004) Cannabis and brain morphology in recent-onset schizophrenia. Schizophr Res 67:305\u2013307","journal-title":"Schizophr Res"},{"key":"451_CR15","doi-asserted-by":"crossref","unstructured":"Carlsson A, Hansson LO, Waters N, Carlsson ML (1999) A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Supplement:2\u20136","DOI":"10.1192\/S0007125000293574"},{"key":"451_CR16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","volume":"41","author":"A Carlsson","year":"2001","unstructured":"Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and gaba in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237\u2013260","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"451_CR17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","volume":"151","author":"MH Chakos","year":"1994","unstructured":"Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994) Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151:1430\u20131436","journal-title":"Am J Psychiatry"},{"key":"451_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2006.09.009","volume":"89","author":"SE Chua","year":"2007","unstructured":"Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, Cheung JP, Yip L, Tai KS, Suckling J, McAlonan GM (2007) Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 89:12\u201321","journal-title":"Schizophr Res"},{"key":"451_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S0033291708004212","volume":"39","author":"SE Chua","year":"2009","unstructured":"Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaemper N, Cheung V, Suckling J, McAlonan GM (2009) Early striatal hypertrophy in first-episode psychosis within 3\u00a0weeks of initiating antipsychotic drug treatment. Psychol Med 39:793\u2013800","journal-title":"Psychol Med"},{"key":"451_CR20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1176\/ajp.147.10.1374","volume":"147","author":"LJ Cohen","year":"1990","unstructured":"Cohen LJ, Test MA, Brown RL (1990) Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 147:602\u2013607","journal-title":"Am J Psychiatry"},{"key":"451_CR21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF02191582","volume":"243","author":"C Colombo","year":"1994","unstructured":"Colombo C, Bonfanti A, Scarone S (1994) Anatomical characteristics of the corpus callosum and clinical correlates in schizophrenia. Eur Arch Psychiatry Clin Neurosci 243:244\u2013248","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR22","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4088\/JCP.v68n1215","volume":"68","author":"MT Compton","year":"2007","unstructured":"Compton MT, Whicker NE, Hochman KM (2007) Alcohol and cannabis use in urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms. J Clin Psychiatry 68:1939\u20131945","journal-title":"J Clin Psychiatry"},{"key":"451_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/09540260701486282","volume":"19","author":"TJ Crow","year":"2007","unstructured":"Crow TJ, Paez P, Chance SA (2007) Callosal misconnectivity and the sex difference in psychosis. Int Rev Psychiatry 19:449\u2013457","journal-title":"Int Rev Psychiatry"},{"key":"451_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Copolov D (2001) Studies on [3h]cp-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315","journal-title":"Neuroscience"},{"key":"451_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/YCO.0b013e3282f51266","volume":"21","author":"LE DeLisi","year":"2008","unstructured":"DeLisi LE (2008) The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry 21:140\u2013150","journal-title":"Curr Opin Psychiatry"},{"key":"451_CR26","first-page":"242","volume":"114","author":"T Demirakca","year":"2011","unstructured":"Demirakca T, Sartorius A, Ende G, Meyer N, Welzel H, Skopp G, Mann K, Hermann D (2011) Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend 114:242\u2013245","journal-title":"Drug Alcohol Depend"},{"key":"451_CR27","volume-title":"The human brain, surface, three-dimensional sectional anatomy and MRI","author":"HM Duvernoy","year":"1991","unstructured":"Duvernoy HM (1991) The human brain, surface, three-dimensional sectional anatomy and MRI. Springer, Wien"},{"key":"451_CR28","volume-title":"The human hippocampus, functional anatomy, vascularization and serial sections with MRI","author":"HM Duvernoy","year":"1998","unstructured":"Duvernoy HM (1998) The human hippocampus, functional anatomy, vascularization and serial sections with MRI. Springer, Wien"},{"key":"451_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1503\/jpn.090049","volume":"35","author":"BH Ebdrup","year":"2010","unstructured":"Ebdrup BH, Glenthoj B, Rasmussen H, Aggernaes B, Langkilde AR, Paulson OB, Lublin H, Skimminge A, Baare W (2010) Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J Psychiatry Neurosci 35:95\u2013104","journal-title":"J Psychiatry Neurosci"},{"key":"451_CR30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/appi.ajp.2008.07101562","volume":"165","author":"I Ellison-Wright","year":"2008","unstructured":"Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008) The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165:1015\u20131023","journal-title":"Am J Psychiatry"},{"key":"451_CR31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","volume":"33","author":"J Endicott","year":"1976","unstructured":"Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766\u2013771","journal-title":"Arch Gen Psychiatry"},{"key":"451_CR32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0306-4603(98)00075-6","volume":"23","author":"M Farrell","year":"1998","unstructured":"Farrell M, Howes S, Taylor C, Lewis G, Jenkins R, Bebbington P, Jarvis M, Brugha T, Gill B, Meltzer H (1998) Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey. Addict Behav 23:909\u2013918","journal-title":"Addict Behav"},{"key":"451_CR33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1176\/appi.ajp.159.5.866","volume":"159","author":"M Frumin","year":"2002","unstructured":"Frumin M, Golland P, Kikinis R, Hirayasu Y, Salisbury DF, Hennen J, Dickey CC, Anderson M, Jolesz FA, Grimson WE, McCarley RW, Shenton ME (2002) Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry 159:866\u2013868","journal-title":"Am J Psychiatry"},{"key":"451_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pscychresns.2006.10.002","volume":"154","author":"A Glenthoj","year":"2007","unstructured":"Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baare WF (2007) Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 154:199\u2013208","journal-title":"Psychiatry Res"},{"key":"451_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eurpsy.2009.10.001","volume":"26","author":"N Goto","year":"2011","unstructured":"Goto N, Yoshimura R, Kakeda S, Moriya J, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, Ueda N, Korogi Y, Nakamura J (2011) Comparison of brain n-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls. Eur Psychiatry 26:57\u201363","journal-title":"Eur Psychiatry"},{"key":"451_CR36","unstructured":"Guy W; National Institute of Mental Health Psychopharmacology Research Branch Early Clinical Drug Evaluation Program (1976) Clinical global impressions. In: ECDEU assessment manual for psychopharmacology. National Institute for Mental Health, Rockville, MD, pp 218\u2013222"},{"key":"451_CR37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2007.12.005","volume":"63","author":"M Hajos","year":"2008","unstructured":"Hajos M, Hoffmann WE, Kocsis B (2008) Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63:1075\u20131083","journal-title":"Biol Psychiatry"},{"key":"451_CR38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archneur.55.2.193","volume":"55","author":"H Hampel","year":"1998","unstructured":"Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI (1998) Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 55:193\u2013198","journal-title":"Arch Neurol"},{"key":"451_CR39","doi-asserted-by":"crossref","unstructured":"Hasan A, Wobrock T, Falkai P, Schneider-Axmann T, Guse B, Backens M, Ecker UK, Heimes J, Galea JM, Gruber O, Scherk H (2011) Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study. World J Biol Psychiatry [Epub ahead of print]","DOI":"10.3109\/15622975.2011.620002"},{"key":"451_CR40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1176\/ajp.152.6.856","volume":"152","author":"TW Haywood","year":"1995","unstructured":"Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA (1995) Predicting the \u201crevolving door\u201d phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152:856\u2013861","journal-title":"Am J Psychiatry"},{"key":"451_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","volume":"330","author":"C Henquet","year":"2005","unstructured":"Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330:11","journal-title":"BMJ"},{"key":"451_CR42","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.biopsych.2006.08.027","volume":"61","author":"D Hermann","year":"2007","unstructured":"Hermann D, Sartorius A, Welzel H, Walter S, Skopp G, Ende G, Mann K (2007) Dorsolateral prefrontal cortex n-acetylaspartate\/total creatine (NAA\/tCr) loss in male recreational cannabis users. Biol Psychiatry 61:1281\u20131289","journal-title":"Biol Psychiatry"},{"key":"451_CR43","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.2174\/138161212802884825","volume":"18","author":"D Hermann","year":"2012","unstructured":"Hermann D, Schneider M (2012) Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. Curr Pharm Des 18:4897\u20134905","journal-title":"Curr Pharm Des"},{"key":"451_CR44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0006-3223(94)91237-8","volume":"35","author":"AL Hoff","year":"1994","unstructured":"Hoff AL, Neal C, Kushner M, DeLisi LE (1994) Gender differences in corpus callosum size in first-episode schizophrenics. Biol Psychiatry 35:913\u2013919","journal-title":"Biol Psychiatry"},{"key":"451_CR45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"451_CR46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/23.2.195","volume":"23","author":"B Kovasznay","year":"1997","unstructured":"Kovasznay B, Fleischer J, Tanenberg-Karant M, Jandorf L, Miller AD, Bromet E (1997) Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 23:195\u2013201","journal-title":"Schizophr Bull"},{"key":"451_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaac.2011.11.001","volume":"51","author":"S Kumra","year":"2012","unstructured":"Kumra S, Robinson P, Tambyraja R, Jensen D, Schimunek C, Houri A, Reis T, Lim K (2012) Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry 51:171\u2013180","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"451_CR48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/schbul\/sbp099","volume":"37","author":"M Leung","year":"2011","unstructured":"Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, Chua S, McAlonan G (2011) Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull 37:199\u2013211","journal-title":"Schizophr Bull"},{"key":"451_CR49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/7854_2010_53","volume":"4","author":"JJ Levitt","year":"2010","unstructured":"Levitt JJ, Bobrow L, Lucia D, Srinivasan P (2010) A selective review of volumetric and morphometric imaging in schizophrenia. Curr Top Behav Neurosci 4:243\u2013281","journal-title":"Curr Top Behav Neurosci"},{"key":"451_CR50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","volume":"51","author":"DH Linszen","year":"1994","unstructured":"Linszen DH, Dingemans PM, Lenior ME (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 51:273\u2013279","journal-title":"Arch Gen Psychiatry"},{"key":"451_CR51","volume-title":"Atlas of the human brain","author":"JK Mai","year":"2008","unstructured":"Mai JK, Paxinos G, Voss T (2008) Atlas of the human brain. Academic Press, New York"},{"key":"451_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-012-0346-3","volume":"263","author":"B Malchow","year":"2013","unstructured":"Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T (2013) Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci 263:3\u201313","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.09.020","volume":"133","author":"SL Matheson","year":"2011","unstructured":"Matheson SL, Shepherd AM, Laurens KR, Carr VJ (2011) A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res 133:133\u2013142","journal-title":"Schizophr Res"},{"key":"451_CR54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004060050104","volume":"249","author":"EM Meisenzahl","year":"1999","unstructured":"Meisenzahl EM, Frodl T, Greiner J, Leinsinger G, Maag KP, Heiss D, Hahn K, Hegerl U, Moller HJ (1999) Corpus callosum size in schizophrenia\u2014a magnetic resonance imaging analysis. Eur Arch Psychiatry Clin Neurosci 249:305\u2013312","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","volume":"370","author":"TH Moore","year":"2007","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370:319\u2013328","journal-title":"Lancet"},{"key":"451_CR56","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrn2253","volume":"8","author":"RM Murray","year":"2007","unstructured":"Murray RM, Morrison PD, Henquet C, Di Forti M (2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8:885\u2013895","journal-title":"Nat Rev Neurosci"},{"key":"451_CR57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2009.08.022","volume":"179","author":"JM Pelayo-Teran","year":"2010","unstructured":"Pelayo-Teran JM, Perez-Iglesias R, Mata I, Carrasco-Marin E, Vazquez-Barquero JL, Crespo-Facorro B (2010) Catechol-O-methyltransferase (COMT) val158met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications. Psychiatry Res 179:291\u2013296","journal-title":"Psychiatry Res"},{"key":"451_CR58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","volume":"188","author":"M Ranganathan","year":"2006","unstructured":"Ranganathan M, D\u2019Souza DC (2006) The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188:425\u2013444","journal-title":"Psychopharmacology"},{"key":"451_CR59","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"JL Rapoport","year":"2012","unstructured":"Rapoport JL, Giedd JN, Gogtay N (2012) Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 17:1228\u20131238","journal-title":"Mol Psychiatry"},{"key":"451_CR60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/oxfordjournals.schbul.a033338","volume":"24","author":"P Rasanen","year":"1998","unstructured":"Rasanen P, Tiihonen J, Isohanni M, Rantakallio P, Lehtonen J, Moring J (1998) Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort. Schizophr Bull 24:437\u2013441","journal-title":"Schizophr Bull"},{"key":"451_CR61","doi-asserted-by":"crossref","unstructured":"Rathbone J, Variend H, Mehta H (2008) Cannabis and schizophrenia. Cochrane Database Syst Rev (3):CD004837. doi: 10.1002\/14651858.CD004837.pub2","DOI":"10.1002\/14651858.CD004837.pub2"},{"key":"451_CR62","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"DA Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511\u20132518","journal-title":"JAMA"},{"key":"451_CR63","doi-asserted-by":"crossref","unstructured":"Sanchez-Torres AM, Basterra V, Rosa A, Fananas L, Zarzuela A, Ibanez B, Peralta V, Cuesta MJ (2013) Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]","DOI":"10.1007\/s00406-013-0404-5"},{"key":"451_CR64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-199301000-00006","volume":"181","author":"JP Seibyl","year":"1993","unstructured":"Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Charney DS (1993) Effects of cocaine on hospital course in schizophrenia. J Nerv Ment Dis 181:31\u201337","journal-title":"J Nerv Ment Dis"},{"key":"451_CR65","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neubiorev.2011.12.015","volume":"36","author":"AM Shepherd","year":"2012","unstructured":"Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36:1342\u20131356","journal-title":"Neurosci Biobehav Rev"},{"key":"451_CR66","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jama.287.9.1123","volume":"287","author":"N Solowij","year":"2002","unstructured":"Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, Christiansen K, McRee B, Vendetti J (2002) Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287:1123\u20131131","journal-title":"JAMA"},{"key":"451_CR67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF02190250","volume":"242","author":"M Soyka","year":"1993","unstructured":"Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, Immler B, Sand P (1993) Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 242:362\u2013372","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR68","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.npp.1300850","volume":"30","author":"RG Steen","year":"2005","unstructured":"Steen RG, Hamer RM, Lieberman JA (2005) Measurement of brain metabolites by 1\u00a0h magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30:1949\u20131962","journal-title":"Neuropsychopharmacology"},{"key":"451_CR69","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.188.6.510","volume":"188","author":"RG Steen","year":"2006","unstructured":"Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188:510\u2013518","journal-title":"Br J Psychiatry"},{"key":"451_CR70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2004.10.006","volume":"75","author":"J Stirling","year":"2005","unstructured":"Stirling J, Lewis S, Hopkins R, White C (2005) Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res 75:135\u2013137","journal-title":"Schizophr Res"},{"key":"451_CR71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-9964(95)00068-2","volume":"20","author":"CD Swofford","year":"1996","unstructured":"Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB (1996) Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 20:145\u2013151","journal-title":"Schizophr Res"},{"key":"451_CR72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1192\/bjp.bp.106.024521","volume":"190","author":"PR Szeszko","year":"2007","unstructured":"Szeszko PR, Robinson DG, Sevy S, Kumra S, Rupp CI, Betensky JD, Lencz T, Ashtari M, Kane JM, Malhotra AK, Gunduz-Bruce H, Napolitano B, Bilder RM (2007) Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry 190:230\u2013236","journal-title":"Br J Psychiatry"},{"key":"451_CR73","volume-title":"Co-planar stereotaxic atlas of the human brain","author":"J Talairach","year":"1988","unstructured":"Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, Stuttgart"},{"key":"451_CR74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0006-3223(98)00096-1","volume":"44","author":"P Tibbo","year":"1998","unstructured":"Tibbo P, Nopoulos P, Arndt S, Andreasen NC (1998) Corpus callosum shape and size in male patients with schizophrenia. Biol Psychiatry 44:405\u2013412","journal-title":"Biol Psychiatry"},{"key":"451_CR75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pscychresns.2008.09.007","volume":"173","author":"M Walterfang","year":"2009","unstructured":"Walterfang M, Wood AG, Reutens DC, Wood SJ, Chen J, Velakoulis D, McGorry PD, Pantelis C (2009) Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis. Psychiatry Res 173:77\u201382","journal-title":"Psychiatry Res"},{"key":"451_CR76","doi-asserted-by":"crossref","unstructured":"Welch KA, Stanfield AC, McIntosh AM, Whalley HC, Job DE, Moorhead TW, Owens DG, Lawrie SM, Johnstone EC (2011) Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia. Br J Psychiatry 199:386\u2013390","DOI":"10.1192\/bjp.bp.110.090175"},{"key":"451_CR77","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.schres.2013.03.001","volume":"147","author":"T Wobrock","year":"2013","unstructured":"Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW, group Es (2013) Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the eufest study. Schizophr Res 147:132\u2013139","journal-title":"Schizophr Res"},{"key":"451_CR78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00406-008-0831-x","volume":"259","author":"T Wobrock","year":"2009","unstructured":"Wobrock T, Sittinger H, Behrendt B, D\u2019Amelio R, Falkai P (2009) Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci 259:28\u201336","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00406-006-0707-x","volume":"257","author":"T Wobrock","year":"2007","unstructured":"Wobrock T, Sittinger H, Behrendt B, D\u2019Amelio R, Falkai P, Caspari D (2007) Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 257:203\u2013210","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"451_CR80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.58.4.457","volume":"58","author":"PW Woodruff","year":"1995","unstructured":"Woodruff PW, McManus IC, David AS (1995) Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry 58:457\u2013461","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"451_CR81","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/schbul\/sbq079","volume":"38","author":"M Yucel","year":"2012","unstructured":"Yucel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ, McGorry PD, Pantelis C (2012) The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull 38:316\u2013330","journal-title":"Schizophr Bull"},{"key":"451_CR82","first-page":"234","volume":"118","author":"K Zilles","year":"1972","unstructured":"Zilles K (1972) Biometrische analyse der frischvolumina verschiedener prosencephaler hirnregionen von 78 menschlichen, adulten gehirnen. Gegenbaurs Morphol Jahrb 118:234\u2013273","journal-title":"Gegenbaurs Morphol Jahrb"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0451-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-013-0451-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-013-0451-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T19:00:17Z","timestamp":1564254017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-013-0451-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,2]]},"references-count":82,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s00406-013-0451-y","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,2]]}}}